Stomach Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People aged 18 to 75 years old
- People who have been diagnosed with stomach cancer confirmed by a laboratory tissue test
- People who have had a specific type of stomach cancer surgery that removes the cancer completely, including at least 16 lymph nodes (called D2, R0 radical resection)
- People who have had a laparoscopic (keyhole) surgery to remove the lower part of the stomach
- People whose cancer has not spread to distant parts of the body, and is at a stage described as T2–4aNxM0 (confirm with trial site)
- People with a life expectancy of more than 6 months
- People who are physically well enough to tolerate abdominal surgery, with organs functioning adequately
- People who have never previously received chemotherapy or radiotherapy
- People who score above 60 on a standard health and activity scale called the Karnofsky Performance Status
- People who score 0 or 1 on another standard health scale called the ECOG Performance Status, meaning they are fully active or have only minor limitations in physical activity
- People who have no other serious ongoing illnesses
- People who are willing and able to follow the trial requirements throughout the study period
- People who have provided written consent to participate
Who may not be able to join:
- People who are pregnant or breastfeeding
- People with serious liver disease (such as cirrhosis), serious kidney disease, serious respiratory disease, or poorly controlled diabetes or high blood pressure
- People with significant heart conditions, such as heart failure, coronary artery disease symptoms, difficult-to-control irregular heartbeat, a heart attack within the past 6 months, or heart insufficiency
- People who have had an organ transplant and require medication to prevent rejection
- People with severe or uncontrolled recurring infections, or other serious ongoing illnesses
- People who have had another type of cancer within the past 5 years (excluding certain easily treated skin cancers and early-stage cervical cancer)
- People with a psychiatric (mental health) condition that requires treatment
- People with any history of organ transplantation
- People who are currently taking part in, or have taken part in, another clinical trial within the 6 months before this study begins, or who participate in another trial during this study
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +86 022-23340123-1061
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
The lymph node metastasis rates in No.4sb-R, No.4sb-C and No.4d groups.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.